Furthermore, in contrast to previous studies (12, 17, 18), our study distinctly includes ER status, providing a more comprehensive overview of evidence on impact of both BRCA mutation and receptor status on fertility outcomes of BC patients. This evidence concerns the gene ESR1 and breast cancer.